CITIGROUP INC - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 135 filers reported holding IMMUNOVANT INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$4,849,272
+190.0%
126,316
+43.3%
0.00%
+300.0%
Q2 2023$1,671,959
-70.3%
88,137
-75.7%
0.00%
-66.7%
Q1 2023$5,632,720
+209.4%
363,167
+254.1%
0.00%
+200.0%
Q4 2022$1,820,635
+10609.6%
102,571
+3366.4%
0.00%
Q3 2022$17,000
-22.7%
2,959
-47.9%
0.00%
Q2 2022$22,000
-24.1%
5,675
+6.6%
0.00%
Q1 2022$29,000
-97.8%
5,322
-96.6%
0.00%
-100.0%
Q4 2021$1,316,000
-44.9%
154,499
-43.8%
0.00%0.0%
Q3 2021$2,390,000
-29.3%
275,049
-14.0%
0.00%
-50.0%
Q2 2021$3,381,000
-13.1%
319,878
+31.8%
0.00%
-33.3%
Q1 2021$3,892,000
+366.7%
242,621
+1243.3%
0.00%
Q4 2020$834,000
+983.1%
18,062
+722.9%
0.00%
Q3 2020$77,000
-75.8%
2,195
-83.2%
0.00%
Q2 2020$318,000
+1172.0%
13,080
+703.4%
0.00%
Q1 2020$25,0001,6280.00%
Other shareholders
IMMUNOVANT INC shareholders Q4 2022
NameSharesValueWeighting ↓
Alpine Global Management, LLC 4,448,017$17,347,0004.39%
Deep Track Capital, LP 9,455,000$36,875,0002.42%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 233$60,000,0000.63%
Octagon Capital Advisors LP 579,061$2,258,0000.60%
Eventide Asset Management 5,372,512$20,953,0000.45%
WITTENBERG INVESTMENT MANAGEMENT, INC. 174,000$679,0000.29%
Frazier Life Sciences Management, L.P. 585,759$2,284,0000.22%
BCK CAPITAL MANAGEMENT LP 54,293$212,0000.16%
PLATINUM INVESTMENT MANAGEMENT LTD 777,590$3,033,0000.12%
Bridgefront Capital, LLC 15,649$61,0000.07%
View complete list of IMMUNOVANT INC shareholders